UCB has unveiled data from a double-blind, placebo-controlled study, which found that Neupro (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure (NSBP) elevations associated with periodic limb movements during ...
Tags: RLS Patients, UCB
GlaxoSmithKline (GSK) and XenoPort have gained FDA approval for Horizant (gabapentin enacarbil) extended-release tablets for postherpetic neuralgia (PHN). A single 12-week principal efficacy trial and two supportive studies that met their ...
UCB has launched Neupro (Rotigotine Transdermal System) in US pharmacies for the treatment of Parkinson's disease (PD) and Restless Legs Syndrome (RLS). Neupro received the US Food and Drug Administration approval on 3 April 2012. UCB ...
Tags: Neupro, Rotigotine Transdermal System, PD, RLS
Astellas Pharma and XenoPort have announced the introduction of Regnite (gabapentin enacarbil) extended-release tablets in Japan for the treatment of moderate-to-severe primary restless legs syndrome (RLS). Regnite, which was discovered ...
Tags: Rls Drug, Restless legs syndrome, Regnite extended-release tablets